Medrx Co. Ltd.

Medrx Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY140.53
Market Cap
JPY7.22 B
Shares Outstanding
12.71 M
Public Float
8.66 M

Profile

Address
431-7 Nishiyama
Higashikagawa Kagawa 769
Japan
Employees -
Website http://www.medrx.co.jp
Updated 07/08/2019
Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.

Financials

View All

Masayoshi Matsumura
Chairman
Yonehiro Matsumura
President & Representative Director